Insight into the pharmacokinetic behavior of tanshinone IIA in the treatment of Crohn’s disease: comparative data for tanshinone IIA and its two glucuronidated metabolites in normal and recurrent colitis models after oral administration

References

• Bai A, Lu N, Guo Y, Fan X. (2008). Tanshinone IIA ameliorates trinitrobenzene sulfonic acid (TNBS)-induced murine colitis. Dig Dis Sci 53:421–8
   PubMed Web of Science ®Google Scholar
• Bi HC, Zuo Z, Chen X, et al (2008). Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from Salvia miltiorrhiza for the treatment of ischaemic heart diseases. Xenobiotica 38:185–222
   PubMed Web of Science ®Google Scholar
• Cheng X, Liu F, Yan T, et al (2012). Metabolic profile, enzyme kinetics, and reaction phenotyping of β-lapachone metabolism in human liver and intestine in vitro. Mol Pharm 9:3476–85
   PubMed Web of Science ®Google Scholar
• Cheroutre H. (2006). In IBD eight can come before four. Gastroenterology 131:667–70
   PubMed Web of Science ®Google Scholar
• Dieleman LA, Palmen MJ, Akol H, et al (1998). Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114:385–91
   PubMed Web of Science ®Google Scholar
• Eeckhoudt SL, Evrard PA, Verbeeck RK. (1997). Biliary excretion and enterohepatic cycling of R- and S-flurbiprofen in the rat. Drug Metab Dispos 25:428–30
   PubMed Web of Science ®Google Scholar
• Fan GW, Gao XM, Wang H, et al (2009). The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS. J Steroid Biochem Mol Biol 113:275–80
   PubMed Web of Science ®Google Scholar
• Granero GE, Amidon GL. (2008). Possibility of enterohepatic recycling of ketoprofen in dogs. Int J Pharm 349:166–71
   PubMed Web of Science ®Google Scholar
• Hanson ML, Hixon JA, Li W, et al (2014). Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice. Gastroenterology 146:210–21 e13
   PubMed Web of Science ®Google Scholar
• Hao H, Wang G, Cui N, et al (2006a). Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion. Planta Med 72:1311–17
   PubMed Web of Science ®Google Scholar
• Hao H, Wang G, Cui N, et al (2007). Identification of a novel intestinal first pass metabolic pathway: NQO1 mediated quinone reduction and subsequent glucuronidation. Curr Drug Metab 8:137–49
   PubMed Web of Science ®Google Scholar
• Hao H, Wang G, Li P, et al (2006b). Simultaneous quantification of cryptotanshinone and its active metabolite tanshinone IIA in plasma by liquid chromatography/tandem mass spectrometry (LC-MS/MS). J Pharm Biomed Anal 40:382–8
   PubMed Web of Science ®Google Scholar
• He W, Yang K, Fan L, et al (2015). Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability. Int J Pharm 495:9–18
   PubMed Web of Science ®Google Scholar
• Hofmann AF. (1999). Bile acids: the good, the bad, and the ugly. News Physiol Sci 14:24–9
   PubMedGoogle Scholar
• Kozuch PL, Hanauer SB. (2008). Treatment of inflammatory bowel disease: a review of medical therapy. World J Gastroenterol 14:354–77
   PubMed Web of Science ®Google Scholar
• Kremer B, Mariman R, van Erk M, et al (2012). Temporal colonic gene expression profiling in the recurrent colitis model identifies early and chronic inflammatory processes. PLoS One 7:e50388
   PubMed Web of Science ®Google Scholar
• Li J, Wang G, Li P, Hao H. (2005). Simultaneous determination of tanshinone IIA and cryptotanshinone in rat plasma by liquid chromatography-electrospray ionisation-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 826:26–30
   PubMed Web of Science ®Google Scholar
• Li P, Wang GJ, Li J, et al (2006). Identification of tanshinone IIA metabolites in rat liver microsomes by liquid chromatography-tandem mass spectrometry. J Chromatogr A 1104:366–9
   PubMed Web of Science ®Google Scholar
• Li Y, Guo Y, Chen Y, et al (2015). Establishment of an interleukin-1beta-induced inflammation-activated endothelial cell-smooth muscle cell-mononuclear cell co-culture model and evaluation of the anti-inflammatory effects of tanshinone IIA on atherosclerosis. Mol Med Rep 12:1665–76
   PubMed Web of Science ®Google Scholar
• Liu J, Zhou F, Chen Q, et al (2015). Chronic inflammation up-regulates P-gp in peripheral mononuclear blood cells via the STAT3/Nf-kappab pathway in 2,4,6-trinitrobenzene sulfonic acid-induced colitis mice. Sci Rep 5:13558
   PubMed Web of Science ®Google Scholar
• Liu M, Wang Q, Liu F, et al (2013). UDP-glucuronosyltransferase 1A compromises intracellular accumulation and anti-cancer effect of tanshinone IIA in human colon cancer cells. PLoS One 8:e79172
   PubMed Web of Science ®Google Scholar
• Marafini I, Di Fusco D, Calabrese E, et al (2015). Antisense approach to inflammatory bowel disease: prospects and challenges. Drugs 75:723–30
   PubMed Web of Science ®Google Scholar
• Mariman R, Kremer B, van Erk M, et al (2012). Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics. Inflamm Bowel Dis 18:1424–33
   PubMed Web of Science ®Google Scholar
• Meng Z, Meng L, Wang K, et al (2015). Enhanced hepatic targeting, biodistribution and antifibrotic efficacy of tanshinone IIA loaded globin nanoparticles. Eur J Pharm Sci 73:35–43
   PubMed Web of Science ®Google Scholar
• Monteleone I, Pallone F, Monteleone G. (2011). Th17-related cytokines: new players in the control of chronic intestinal inflammation. BMC Med 9:122
   PubMed Web of Science ®Google Scholar
• Neurath MF, Fuss I, Kelsall BL, et al (1995). Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182:1281–90
   PubMed Web of Science ®Google Scholar
• Priymenko N, Garnier F, Ferre JP, et al (1998). Enantioselectivity of the enterohepatic recycling of carprofen in the dog. Drug Metab Dispos 26:170–6
   PubMed Web of Science ®Google Scholar
• Ramirez-Alcantara V, Montrose MH. (2014). Acute murine colitis reduces colonic 5-aminosalicylic acid metabolism by regulation of N-acetyltransferase-2. Am J Physiol Gastrointest Liver Physiol 306:G1002–10
   PubMed Web of Science ®Google Scholar
• Shinkuma D, Hamaguchi T, Yamanaka Y, et al (1985). Influence of bile on the gastrointestinal absorption of phenytoin in rats. Chem Pharm Bull (Tokyo) 33:5023–7
   PubMed Web of Science ®Google Scholar
• Siegmund B, Lehr HA, Fantuzzi G, Dinarello CA. (2001). IL-1 beta-converting enzyme (caspase-1) in intestinal inflammation. Proc Natl Acad Sci USA 98:13249–54
   PubMed Web of Science ®Google Scholar
• Sun S, Yin Y, Yin X, et al (2012). Anti-nociceptive effects of Tanshinone IIA (TIIA) in a rat model of complete Freund’s adjuvant (CFA)-induced inflammatory pain. Brain Res Bull 88:581–8
   PubMed Web of Science ®Google Scholar
• Traber MG, Kayden HJ, Green JB, Green MH. (1986). Absorption of water-miscible forms of vitamin E in a patient with cholestasis and in thoracic duct-cannulated rats. Am J Clin Nutr 44:914–23
   PubMed Web of Science ®Google Scholar
• Wang Q, Hao H, Zhu X, et al (2010). Regioselective glucuronidation of tanshinone iia after quinone reduction: identification of human UDP-glucuronosyltransferases, species differences, and interaction potential. Drug Metab Dispos 38:1132–40
   PubMed Web of Science ®Google Scholar
• Wen XD, Wang CZ, Yu C, et al (2013). Salvia miltiorrhiza (dan shen) significantly ameliorates colon inflammation in dextran sulfate sodium induced colitis. Am J Chin Med 41:1097–108
   PubMed Web of Science ®Google Scholar
• Worthington JJ. (2015). The intestinal immunoendocrine axis: novel cross-talk between enteroendocrine cells and the immune system during infection and inflammatory disease. Biochem Soc Trans 43:727–33
   PubMed Web of Science ®Google Scholar
• Xu D, Yu H, Yu Q, et al (2014). Salvia miltiorrhiza increases the expression of transcription factor Foxp3 in experimental murine colitis. Mol Med Rep 9:1947–51
   PubMed Web of Science ®Google Scholar
• Yu X, Xu H, Hu M, et al (2015). Ginsenoside Rg3 bile salt-phosphatidylcholine-based mixed micelles: design, characterization, and evaluation. Chem Pharm Bull (Tokyo) 63:361–8
   PubMed Web of Science ®Google Scholar
• Yu XY, Lin SG, Zhou ZW, et al (2007). Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge. Curr Drug Metab 8:325–40
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang M, Guan S, et al (2006). A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhiza. J Pharmacol Exp Ther 317:1285–94
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhou F, Wu X, et al (2010). 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions. Drug Metab Dispos 38:2179–87
   PubMed Web of Science ®Google Scholar
• Zhou Q, Price DD, Dreher KL, et al (2012). Localized colonic stem cell transplantation enhances tissue regeneration in murine colitis. J Cell Mol Med 16:1900–15
   PubMed Web of Science ®Google Scholar
• Zhou X, Cao L, Jiang C, et al (2014). PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis. Nat Commun 5:4573–87
   PubMed Web of Science ®Google Scholar
• Zhou X, Xie Y, Qi Q, et al (2013). Disturbance of hepatic and intestinal UDP-glucuronosyltransferase in rats with trinitrobenzene sulfonic acid-induced colitis. Drug Metab Pharmacokinet 28:305–13
   PubMed Web of Science ®Google Scholar